These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37291045)

  • 1. Comment on "Definite chemoradiotherapy for early-stage bulky cervical cancer".
    Zhang W; Ruan Y; Ye L; Liu M
    J Formos Med Assoc; 2024 Mar; 123(3):416-417. PubMed ID: 37291045
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term treatment outcomes/toxicities of definite chemoradiotherapy (intensity-modulated radiation therapy) for early-stage "bulky" cervical cancer and survival impact of histological subtype.
    Hsieh HY; Lu CH; Wang L
    J Formos Med Assoc; 2023 Mar; 122(3):221-229. PubMed ID: 36379808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Chemoradiotherapy in Locally Advanced Bulky Squamous Cell Carcinoma of the Uterine Cervix.
    Nakao Y; Hashiguchi M; Nishiyama S; Aihara S; Iwasaka T; Yokoyama M
    Int J Gynecol Cancer; 2017 Nov; 27(9):1943-1948. PubMed ID: 28786876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
    Kokka F; Bryant A; Brockbank E; Powell M; Oram D
    Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Stage IB2, IIA and IIB cervical carcinoma without lymph node extension treated with neoadjuvant chemoradiotherapy].
    Monnier L; Touboul E; Daraï E; Lefranc JP; Lauratet B; Ballester M; Huguet F
    Bull Cancer; 2016 Feb; 103(2):164-72. PubMed ID: 26822905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].
    Tang Q; Tu YQ; Chen JH; Lyu XJ; Yan DD
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):462-466. PubMed ID: 29936774
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and prognostic factors of concurrent chemoradiotherapy in patients with stage Ib3 and IIa2 cervical cancer.
    Liu T; Kong W; Liu Y; Song D
    Ginekol Pol; 2020; 91(2):57-61. PubMed ID: 32141049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer.
    Harima Y; Ohguri T; Imada H; Sakurai H; Ohno T; Hiraki Y; Tuji K; Tanaka M; Terashima H
    Int J Hyperthermia; 2016 Nov; 32(7):801-8. PubMed ID: 27418208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy followed by radical surgery versus concurrent chemoradiotherapy in patients with FIGO stage IIB cervical cancer: the CSEM 006 study.
    Tu H; Huang H; Ouyang Y; Liu Q; Xian B; Song K; Chen G; Shen Y; Liu J
    Int J Gynecol Cancer; 2021 Jan; 31(1):129-133. PubMed ID: 32522771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematological parameters during concurrent chemoradiotherapy as potential prognosticators in patients with stage IIB cervical cancer.
    Cho O; Noh OK; Oh YT; Chang SJ; Ryu HS; Lee EJ; Chun M
    Tumour Biol; 2017 Feb; 39(2):1010428317694306. PubMed ID: 28222668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for the Treatment of Cervical Cancer with Bulky Pelvic Lymph Nodes: An Overview of the Current Evidence.
    Tohyama A; Murakami M; Yoshino K
    J UOEH; 2020; 42(4):317-325. PubMed ID: 33268608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent chemoradiotherapy for non-bulky stage IB/II cervical cancer without pelvic node enlargement.
    Wakayama A; Inamine M; Kudaka W; Nagai Y; Nakamoto T; Ooyama T; Ariga T; Kasuya G; Toita T; Aoki Y
    Anticancer Res; 2013 Nov; 33(11):5123-6. PubMed ID: 24222159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of nedaplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a Tohoku Gynecologic Cancer Unit Study.
    Kagabu M; Shoji T; Murakami K; Omi H; Honda T; Miura F; Yokoyama Y; Tokunaga H; Takano T; Ohta T; Shimizu D; Sato N; Soeda S; Watanabe T; Yamada H; Mizunuma H; Yaegashi N; Nagase S; Tase T; Sugiyama T
    Int J Clin Oncol; 2016 Aug; 21(4):735-740. PubMed ID: 26782958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of GGH -401C>T polymorphism on cisplatin-based chemoradiotherapy response and survival in cervical cancer.
    Silva IH; Nogueira-Silva C; Figueiredo T; Lombo L; Faustino I; Catarino R; Nogueira A; Pereira D; Medeiros R
    Gene; 2013 Jan; 512(2):247-50. PubMed ID: 23107767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy after primary treatments for cervical cancer: a critical point of view and review of the literature.
    Angioli R; Luvero D; Aloisi A; Capriglione S; Gennari P; Linciano F; Li Destri M; Scaletta G; Montera R; Plotti F
    Expert Rev Anticancer Ther; 2014 Apr; 14(4):431-9. PubMed ID: 24483847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study.
    Marnitz S; Tsunoda AT; Martus P; Vieira M; Affonso Junior RJ; Nunes J; Budach V; Hertel H; Mustea A; Sehouli J; Scharf JP; Ulrich U; Ebert A; Piwonski I; Kohler C
    Int J Gynecol Cancer; 2020 Dec; 30(12):1855-1861. PubMed ID: 33293284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant Chemoradiotherapy With Image-guided Pulsed Dose Rate Brachytherapy as a Definitive Treatment Modality for Early-stage Cervical Cancer.
    Refaat T; Castelain B; Small W; Elsaid A; Lotfy N; Lartigau E; Nickers P
    Am J Clin Oncol; 2015 Jun; 38(3):289-93. PubMed ID: 23799285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease courses in patients with residual tumor following concurrent chemoradiotherapy for locally advanced cervical cancer.
    Kim JY; Byun SJ; Kim YS; Nam JH
    Gynecol Oncol; 2017 Jan; 144(1):34-39. PubMed ID: 27789082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to comment on "Definite chemoradiotherapy for early-stagebulky cervical cancer".
    Hsieh HY; Lu CH; Wang L
    J Formos Med Assoc; 2024 Mar; 123(3):418-419. PubMed ID: 38129266
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcome of stage IB2-IIB patients with bulky uterine cervical cancer who underwent neoadjuvant chemotherapy followed by radical hysterectomy.
    Uegaki K; Shimada M; Sato S; Deura I; Naniwa J; Sato S; Oishi T; Itamochi H; Harada T; Kigawa J
    Int J Clin Oncol; 2014 Apr; 19(2):348-53. PubMed ID: 23592280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.